SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZMO
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Spekulatius who wrote (282)8/26/2000 1:16:39 PM
From: jeffbas  Read Replies (1) of 438
 
Does anyone know how unique SAGE's capabilities are? Gail Maderis once told me that it could do what it does cheaper, faster and more completely than anyone else, or something like that. However, if SAGE is just one of many similar methods for achieving results it may be nothing special. On the other hand, if it is unigue, as perhaps suggested by deals with Affymetrix and others, it might achieve for GZMO a more genomics like market cap over time, or lead to an acquisition of the company. Any thoughts?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News